Financial statements Biophage Pharma
Cash flow statement of Biophage Pharma
Company age:
Age:
12 y. 11 m. 1 d.
Share capital:
Share capital:
100 000 PLN
Cash inflows of BIOPHAGE PHARMA
|
Year
|
2018
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Net cash from operating expenses | 86 270,56 | -307 660,98 | -200 127,67 | -106 945,20 | -47 859,49 |
| Net cash flow from investing activities | -152 471,94 | -49 858,54 | 20 000,00 | 0,00 | 395 462,18 |
| Net cash flow from financial activities | 0,00 | 198 000,00 | -15 337,50 | -31 758,04 | -26 524,42 |
| Total net cash flow | -66 201,38 | -159 519,52 | -195 465,17 | -138 703,24 | 321 078,27 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.